Marshall Financial Group Acquires Stake in Exact Sciences

The investment firm purchased over 17,000 shares of the medical research company in Q4 2025.

Mar. 23, 2026 at 10:49am

Got story updates? Submit your updates here. ›

Marshall Financial Group LLC acquired a new stake of 17,663 shares in Exact Sciences Corporation (NASDAQ:EXAS) during the fourth quarter, according to a recent SEC filing. The institutional investor's stake in the medical research company is valued at approximately $1.79 million.

Why it matters

Exact Sciences is a leading molecular diagnostics company focused on early cancer detection and prevention. The acquisition of a stake by Marshall Financial Group suggests institutional investor confidence in the company's growth potential and future prospects.

The details

According to the SEC filing, Marshall Financial Group LLC added the 17,663 shares of Exact Sciences to its portfolio in the fourth quarter. Exact Sciences is a medical research company known for its flagship product, the Cologuard DNA screening test for colorectal cancer.

  • Marshall Financial Group LLC acquired the Exact Sciences shares in the fourth quarter of 2025.

The players

Marshall Financial Group LLC

An institutional investment firm that acquired a new stake in Exact Sciences Corporation.

Exact Sciences Corporation

A molecular diagnostics company focused on early cancer detection and prevention, known for its Cologuard colorectal cancer screening test.

Got photos? Submit your photos here. ›

The takeaway

The acquisition of Exact Sciences shares by Marshall Financial Group suggests continued institutional investor confidence in the company's growth prospects as it develops innovative cancer detection technologies.